16-11548820-T-TA
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_001136472.2(LITAF):c.*816_*817insT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000212 in 451,982 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
LITAF
NM_001136472.2 3_prime_UTR
NM_001136472.2 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.13
Genes affected
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000264 (40/151230) while in subpopulation NFE AF= 0.000413 (28/67800). AF 95% confidence interval is 0.000293. There are 0 homozygotes in gnomad4. There are 17 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 40 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LITAF | NM_001136472.2 | c.*816_*817insT | 3_prime_UTR_variant | 4/4 | ENST00000622633.5 | NP_001129944.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LITAF | ENST00000622633.5 | c.*816_*817insT | 3_prime_UTR_variant | 4/4 | 1 | NM_001136472.2 | ENSP00000483114 | P1 | ||
LITAF | ENST00000339430.9 | c.*816_*817insT | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000340118 | P1 | |||
LITAF | ENST00000571688.5 | c.*816_*817insT | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000459533 | P1 | |||
LITAF | ENST00000413364.6 | c.*941_*942insT | 3_prime_UTR_variant | 5/5 | 2 | ENSP00000397958 |
Frequencies
GnomAD3 genomes AF: 0.000264 AC: 40AN: 151230Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
40
AN:
151230
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000201 AC: 26AN: 129082Hom.: 0 AF XY: 0.000255 AC XY: 18AN XY: 70478
GnomAD3 exomes
AF:
AC:
26
AN:
129082
Hom.:
AF XY:
AC XY:
18
AN XY:
70478
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000186 AC: 56AN: 300752Hom.: 0 Cov.: 0 AF XY: 0.000216 AC XY: 37AN XY: 171462
GnomAD4 exome
AF:
AC:
56
AN:
300752
Hom.:
Cov.:
0
AF XY:
AC XY:
37
AN XY:
171462
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000264 AC: 40AN: 151230Hom.: 0 Cov.: 31 AF XY: 0.000230 AC XY: 17AN XY: 73830
GnomAD4 genome
AF:
AC:
40
AN:
151230
Hom.:
Cov.:
31
AF XY:
AC XY:
17
AN XY:
73830
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth disease, type I Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at